Table 5 Pathway enrichment analysis on differentially expressed genes between L2 and N1 group
KEGG pathway | Genes count | Percent | p value |
|---|---|---|---|
Cell adhesion molecules (CAMs) | 32 | 1.8 | 9.60E-09 |
Neuroactive ligand-receptor interaction | 45 | 2.5 | 8.80E-05 |
Melanogenesis | 20 | 1.1 | 5.20E-04 |
Cytokine-cytokine receptor interaction | 30 | 1.7 | 6.80E-04 |
ECM-receptor interaction | 15 | 0.8 | 7.60E-03 |
PPAR signalling pathway | 12 | 0.7 | 2.10E-02 |
Tyrosine metabolism | 8 | 0.4 | 2.30E-02 |
Vascular smooth muscle contraction | 17 | 0.9 | 2.70E-02 |
Calcium signalling pathway | 24 | 1.3 | 2.90E-02 |
Nicotinate and nicotinamide metabolism | 7 | 0.4 | 3.70E-02 |
Focal adhesion | 26 | 1.4 | 4.00E-02 |
TGF-beta signalling pathway | 13 | 0.7 | 4.40E-02 |